(Exact name of small business issuer as specified in its charter)
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification No.)
(Address of principal executive offices)
(Registrant's Telephone number)
(Former Name or Former Address, if Changed Since Last Report)
On November 1, 2011, BehlerMick PS ("BehlerMick") resigned as the Company's independent registered public accounting firm, as a result of BehlerMick's cessation of operations. Concurrent with the resignation of BehlerMick, the Company, through and with the approval of its Board of Directors, engaged MartinelliMick PLLC ("MartinelliMick") as its independent registered public accounting firm. Certain of the professional staff and shareholders of BehlerMick joined MartinelliMick either as employees or partners of MartinelliMick and will continue to practice as members of MartinelliMick.
The report of BehlerMick on the Company's financial statements for the fiscal year ended December 31, 2010 did not contain an adverse opinion or a disclaimer of opinion, and was not qualified or modified as to uncertainty, audit scope, or accounting principles.
In connection with the audit for the past two fiscal years and through October 31, 2011, there were no disagreements with BehlerMick on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of BehlerMick, would have caused BehlerMick to make reference to the subject matter of the disagreements in connection with its audit reports on the Company's financial statements.
The Company is unable to file Exhibit 16, as the predecessor auditor ceased operations and is no longer practicing public accounting.
QuantRx Biomedical Corporation |
By: | /s/ William Fleming |
Name: William Fleming | |
Title: President |